Sio Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,349,274
| Closed | -$24.3M | – | 58 |
|
|
2024
Q3 | $24.3M | Buy |
+1,349,274
| New | +$24.3M | 9.64% | 2 |
|
|
2021
Q2 | – | Sell |
-539,947
| Closed | -$6.23M | – | 96 |
|
|
2021
Q1 | $6.23M | Sell |
539,947
-150,439
| -22% | -$1.74M | 1.26% | 25 |
|
|
2020
Q4 | $6.66M | Sell |
690,386
-261,305
| -27% | -$2.52M | 1.36% | 22 |
|
|
2020
Q3 | $8.58M | Sell |
951,691
-11,105
| -1% | -$100K | 1.7% | 17 |
|
|
2020
Q2 | $11.9M | Buy |
962,796
+390,115
| +68% | +$4.81M | 3.46% | 4 |
|
|
2020
Q1 | $5.14M | Buy |
+572,681
| New | +$5.14M | 1.72% | 18 |
|
|
2017
Q2 | – | Sell |
-69,500
| Closed | -$2.23M | – | 61 |
|
|
2017
Q1 | $2.23M | Buy |
+69,500
| New | +$2.23M | 1.25% | 19 |
|
|
2016
Q1 | – | Sell |
-42,610
| Closed | -$2.8M | – | 50 |
|
|
2015
Q4 | $2.8M | Buy |
+42,610
| New | +$2.8M | 1.24% | 26 |
|